ZhuZhou QianJin Pharmaceutical Co.,Ltd
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhuzhou Qianjin Pharmaceutical Co., Ltd. was founded in 1966, underwent a shareholding reform in 1993, and was listed on the Shanghai Stock Exchange in 2004. The group has 10 holding subsidiaries with approximately 7000 employees. The business scope of the company covers traditional Chinese patent medicines and simple preparations, chemical medicine, Chinese medicine derivatives, drug wholesale and retail, Chinese medicine planting and processing and other fields. In 2005, the "Qianjin" brand trademark was recognized as a well-known trademark in China, and the company was awarded the title of "National Civilized Unit"; In 2018, Qianjin Pharmaceutical (brand "Qianjin") was awarded the title of "Hunan time-honored brand", and the company won titles such as "National Enterprise Management Modernization Innovation Achievement Award", "12th China Main Board Listed Companies Value Top 100", "National Intellectual Property Demonstration Enterprise", and "National Equipment Management Excellent Unit"; In 2019, the company was awarded the title of "National Enterprise Technology Center" and "Best Practice Enterprise of National Enterprise Culture", and was selected as 33rd on the "Top Chinese Medicine Enterprises Ranking"; In 2020, the company was awarded the title of "National Green Factory", and its chairman, Jiang Duan, was awarded the title of "National Excellent Entrepreneur". In 2021, the company was awarded the title of "National Advanced Collective for Women's Achievements". In 2006, the company's flagship product, Gynecological Qianjin Pian, was recognized as a "national secret technology variety"; Since 1998, Gynecological Qianjin Tablets (Capsules) have been a Class A variety in the National Medical Insurance Catalogue and have been selected for the 2009, 2012, and 2018 editions of the National Essential Drug Catalogue; Buxue Yimu Wan (granules) has been a variety of the National Medical Insurance Catalogue since 2010 and has been selected for the 2018 edition of the National Essential Drug Catalogue. Since 2008, the "Qianjin" brand has been on the "Healthy China Brand List" of the Western Conference for 13 consecutive years. |
| Headquarter | Zhuzhou City |
| Establish Date | 8/13/1993 |
| Listed Code | 600479.SH |
| Listed Date | 3/12/2004 |
| Chairman | Jian Shun. |
| CEO | Chen Zhiyong. |
| Website | www.qjyy.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
